Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1061 participants
OBSERVATIONAL
2016-05-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders
NCT07295652
Connectomics in Psychiatric Classification of Bipolar Disorder and Schizophrenia
NCT02756065
Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder
NCT01998516
Socio-cognitive and Biological Responses to Maltreatment
NCT07101107
The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders
NCT03166098
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hospitalized
Hospitalized psychiatric patients
No interventions assigned to this group
Daily hospital
No interventions assigned to this group
Outpatients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* dementia
* mental retardation
* acute psychosis
* intoxication
* inability to answer the questionnaire by themselves
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sveti Ivan Psychiatric Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ena Ivezic
MA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PB Sveti Ivan
Zagreb, , Croatia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jelec V, Bajic Z, Simunovic Filipcic I, Portolan Pajic I, Sentija Knezevic M, Miloloza I, Radic-Kristo D, Benjak T, Jaksic N, Sagud M, Wang W, Filipcic I. Utilization of somatic healthcare in Croatian patients with schizophrenia spectrum disorder, major depression, PTSD and the general population. BMC Psychiatry. 2019 Jun 28;19(1):203. doi: 10.1186/s12888-019-2190-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
komorbiditeti
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.